Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer
NCT01477489
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Veliparib
RADIATION:
Standard radiation treatment
Sponsor
University of Michigan Rogel Cancer Center